Insiders · Profile

Prelack Steven

Director at GALECTIN THERAPEUTICS. Filing since 11 Apr 2014. CIK 0001302315

Company
Date
Role
Action
Shares
Amount
Of holding
11 Apr 2014
Director
Sold, plan not stated
6,000
$71.04K
6.4%
1 decision on file.